Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
Molecular Cancer Research : MCR|June 29, 2021
Membrane-Associated RING-CH 8 Functions as a Novel PD-L1 E3 Ligase to Mediate PD-L1 Degradation Induced by EGFR InhibitorsGuoqing Qian, Jianping Guo, Karin A Vallega, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 2, 2024
TRIM28 promotes tumor growth and metastasis in breast cancer by targeting the BRD7 protein for ubiquitination and degradationChangning Xue, Hanbing Meng, Weihong Niu, et al.
Clinical and Translational Medicine|January 9, 2026
Targeted demethylation of the BRD7 promoter based on CRISPR/dCas9 system inhibits the malignant progression of nasopharyngeal carcinomaJianxia Wei, Yumei Duan, Changning Xue, et al.
Journal of Pathology and Translational Medicine|January 16, 2025
PLUNC downregulates the expression of PD-L1 by inhibiting the interaction of DDX17/β-catenin in nasopharyngeal carcinomaRanran Feng, Yilin Guo, Meilin Chen, et al.
American Journal of Cancer Research|September 11, 2023
Yin Yang 1 suppresses tumor invasion and metastasis in nasopharyngeal carcinoma by negatively regulating eIF4E transcriptional activity and expressionMengna Li, Yumei Duan, Jianxia Wei, et al.
FEBS Letters|June 22, 2005
Expression and functional characterization of LRRC4, a novel brain-specific member of the LRR superfamilyQiuhong Zhang, Jieru Wang, Songqing Fan, et al.
Cancer Research|July 22, 2021
Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, OsimertinibLei Zhu, Zhen Chen, Hongjing Zang, et al.
Cellular & Molecular Immunology|July 5, 2016
BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-кB signaling pathwayRan Zhao, Yukun Liu, Heran Wang, et al.
The Journal of Clinical Investigation|February 16, 2026
Cotargeting DNA topoisomerase II enhances efficacy of RAS-targeted therapy in KRAS-mutant cancer modelsRongzhong Xu, Dongsheng Wang, Guangzhi Ma, et al.
Cancer Science|January 9, 2019
p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53Yao Zhou, Weihong Niu, Yanwei Luo, et al.
Pageof 21